•
Sep 30, 2024
•
/

Ascendis Pharma Q3 2024 Earnings Report

Total Revenue
€56.7M
Previous year: €49.3M
+15.0%
EPS
-€1.69
Previous year: -€2.95
-42.9%
Gross Profit
€42.3M
Previous year: €36.9M
+14.8%
Cash and Equivalents
€624M
Previous year: €455M
+37.0%
Free Cash Flow
-€55.3M
Previous year: -€130M
-57.6%
Total Assets
€1.09B
Previous year: €873M
+24.9%

Ascendis Pharma

Ascendis Pharma